Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is pleased to announce Immunomic’s founder and CEO, William Hearl, Ph.D., has been appointed by Governor Larry Hogan to the Maryland Department of Commerce Life Sciences Advisory Board (LSAB).
{iframe}http://www.businesswire.com/news/home/20171129005015/en/Immunomic-Therapeutics%E2%80%99-Founder-Appointed-Maryland-Life-Sciences{/iframe}